For more than 40 years, Epstein Becker Green has been advising public and private companies—from startups to Fortune 100 companies—on a wide range of corporate transactions. While every transaction is unique, our clients benefit from our extensive corporate experience, multidisciplinary capabilities, and close relationships in the investment and financial communities, as well as the efficiency with which we can handle matters from inception through resolution.

Ranked as one of the nation's largest health care law firms by Modern Healthcare, Epstein Becker Green is regularly called upon to provide corporate and transactional legal guidance to for-profit and nonprofit entities in the ever-changing health care and life sciences industry—including hospitals, health systems, academic medical centers, and universities; medical groups and other physician organizations; health plans and other managed care organizations; medical device and pharmaceutical companies; private equity and venture funds; and health care industry services providers.

Regardless of the industry, however, our corporate attorneys strive to work as members of a client’s business team, offering strategic, comprehensive, and pragmatic guidance and cost-effective solutions. We routinely counsel clients on mergers, acquisitions, and joint ventures; corporate governance issues; commercial contracts; finance matters; outsourcing transactions; private equity and venture capital investments; reorganization and financial restructuring matters; securities issues; and other complex business arrangements.

At the early stages of a proposed transaction, our attorneys work closely with a client’s CEO, general counsel, and governing board to develop a strategy tailored to the client’s business, regulatory, and legal goals. During and after the transaction, we provide counseling to assure that the client's interests are, at all times, maximized and protected.